KFDA approves new anticancer drug
Published: 2007-05-18 07:00:00
Updated: 2007-05-18 07:00:00
The Korea Food and Drug Administration approved a home-grown anticancer medicine CreaVax-RCC developed by Creagene Inc., a local bio-venture company, for sale in the domestic market, the Ministry of Health and Welfare on May 15.
CreaVax-RCC is indicated for the treatment of kidney cancer and h...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
